Harbour Investments’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
Other funds holding MBOT
Harbour Investments's MBOT Position: Q2 2026 in Review
Harbour Investments increased its Microbot Medical (MBOT) stake by 6,500% in Q2 2026, buying an estimated $133 and bringing the position to 66 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #4587.
Harbour Investments first reported a position in MBOT in Q1 2021 and has held it in 6 quarters since. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.
- Harbour Investments held 66 shares of Microbot Medical worth $129 as of Q2 2026.
- Harbour Investments bought 65 Microbot Medical shares in Q2 2026, an estimated $133.
- Microbot Medical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4587 holding.
- Harbour Investments first reported a position in Microbot Medical in Q1 2021 and has held it in 6 quarters since.
- 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.
Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.